Recall Register

Device recall: Straumann Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim (Article 021.5314); implant…

Class II FDA enforcement event 99441. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim may inadvertently contain implants that are 12mm in length instead of 14mm as the labeling would suggest.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Straumann USA LLC started this device recall on 16 Jul 2026. The firm address in the FDA record is in Andover, MA. FDA put the recall in Class II. FDA event 99441 has 1 product record. The first FDA enforcement report date is 19 Aug 2026. The record gives the status Ongoing. 291 of the 710 device events that started in 2026 have more product records. The median device event of 2026 has 1 product record.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

US Nationwide distribution.

Recalling firm

Straumann USA LLC, Andover, MA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 99441: product records
Recall numberProductQuantityClassStatusReport date
Z-2935-2026Straumann Bone Level Tapered (BLT) Implant, D 4.1mm RC, SLActive 14mm, Roxolid, Loxim (Article 021.5314); implant, endosseous, root-form175 unitsClass IIOngoing19 Aug 2026

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2026
710
Share of these events in Class II
87%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
18

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 99441. https://recallregister.com/fda/ii/99441/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: US Nationwide distribution.
What quantity of product is in FDA event 99441?
The FDA record gives this quantity: 175 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2026 have the same class?
87% of the 710 device events that started in 2026 are in Class II.